You are browsing the archive for M&A - 2/4 - peHUB.
Shareholder Representative Services’ latest Q&A features Amr Salahieh. Salahieh is the founder of Shifamed LLC, a Silicon Valley-based medical device incubator founded in 2009. Shifamed recently sold Maya Medical, a medical device company focused on the treatment of hypertension, to Covidien in a deal valued at up to $230 million. Salahieh discusses the incubator model, [...]
Shareholder Representative Services’ latest Q&A features Troy Wilson. Wilson led Intellikine to an acquisition by Millennium, a U.S. subsidiary of Takeda, for up to $310 million. As a serial entrepreneur, he looks for opportunities with clear value inflection points that bring discipline to the development process. He discusses his approach to value creation, the difference [...]
Renaissance Group CEO Says Investment Banking Industry Is “Hugely Oversized,” Mid-Size Banks Face “Killing Zone”
Investment banking faces a shakeout and only large commercial players and boutiques offering outstanding service will survive and prosper, the head of emerging markets banking specialist Renaissance Group told Reuters.
Cambridge Associates reports that limited partners received $93.6 billion from U.S. buyout funds in 2011, the largest annual amount it has recorded since it began tracking the data in 1986. Will the record distributions continue this year?
Life sciences & biotech investors will want to heed the advice guest poster SRS “Achieving the Exit” Q&A subject Michael Gilman offers.
Shareholder Representative Services’ latest Q&A features Steve Papa. Papa led Endeca, the Cambridge, Mass.-based provider of unstructured data management, web commerce and business intelligence software, to an acquisition by Oracle in December 2011. He emphasizes the “relentless pursuit of credibility” to best position a startup for hiring, customer acquisition, and ultimately, achieving the exit. Q: What [...]
Here are the 10 posts that garnered the most unique pageviews from peHUB’s regular readers from Jan. 9 to 13. Coming in at No. 1 was David Toll’s top 10 funds of funds list.
1. Returns Scorecard: 10 Top Funds of Funds – by David Toll
2. Venture-Backed IPO, M&A Markets Might Be Best Thought of as Above Average in 2011: Slideshow – by Mark Boslet
3. New York City Pensions Commit $880 Million to Four Funds – by Gregory Roth
4. Slideshow: Euro Venture Fundraising Takes a Tumble – by Angela Sormani
5. An MBA on Becoming Relevant to an Industry “That’s Doing Fine Without You” – by Connie Loizos
6. Slideshow: The Private Equity Exodus (subscribers only) – by Angela Sormani
7. New Buyout Shop In Philly? – by Bernard Vaughan
8. Carlyle Founders See Big Payday in 2011 – by Greg Roumeliotis, Reuters
9. Sixpoint’s Zoller Fundraising Tips for GPs: Talk to Your LPs and Have a Plan Before You Market – by Luisa Beltran
10. Under Romney, Bain Generated Major Gains and Some Busts, WSJ Says; Plus “When Mitt Romney Came to Town” Video – by Luisa Beltran
Here is confirmation of what most of you in the venture world already know. The market for venture-backed IPOs rebounded in the fourth quarter, but not enough to match the vigorous final three months of 2010. That helped lead all of 2011 down 31% in volume and 41% in dollar value from a year ago, [...]